Kalm Therapeutics (Kalm Tx) is pleased to announce the appointment of Dr. Tomoko Maeda-Chubachi, M.D., Ph.D., as our Chief ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

Follow today’s news live. Biden caught on hot mic telling Albanese and other Quad leaders China 'testing us' 04:43 ...

GSK gained that nod from the FDA in 2017 ... was the first head-to-head study of biologics ever,” Donna Carstens, M.D., AZ’s ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

The legal sector's engagement with the staggering potential of artificial intelligence has surprised long-time observers of ...

Neuberg Diagnostics unveils 'Geniee', a personalised genomics platform offering genetic testing and tailored medicine for ...

PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...

Mackay will join the company on 14 January next year, and has also been appointed as an executive director to the GSK board. This is just the latest in a series of top management changes ...

and will join GSK next April for a transition period, before taking the CFO role and an executive director position on 1 May. Mackay has been CFO at the UK big pharma since the beginning of 2019 ...

Patients with locally advanced cervical cancer were randomized to receive either pembrolizumab or placebo in combination with ...